NYD-SP15 Activators
The functional activity of NYD-SP15 can be indirectly enhanced by a variety of chemical compounds, each acting through distinct mechanisms within cellular signaling pathways. Cyclosporin A, for instance, impacts the calcineurin pathway, leading to an accumulation of cytoplasmic NFAT which might interact with and enhance NYD-SP15. Genistein and other tyrosine kinase inhibitors like it could lead to increased NYD-SP15 activity by preventing phosphorylation of regulatory proteins, thereby indirectly increasing the functional activity of NYD-SP15 through altered signaling pathways. Rapamycin and similar mTOR inhibitors could dephosphorylate proteins within NYD-SP15's regulatory network, enhancing its activity. Inhibitors of protein phosphatases such as Okadaic Acid and Calyculin A can increase the phosphorylation state of proteins within NYD-SP15's signaling network, potentially leading to enhanced NYD-SP15 activity.
Additionally, compounds like SB 203580, LY294002, PD98059, and U0126, which target various kinases (like p38 MAPK, PI3K, MEK, and ERK, can modulate respective pathways and potentially create conditions that favor the activation of NYD-SP15 by altering the phosphorylation status of proteins within those pathways. These inhibitors can cause compensatory cellular responses that may result in the activation of alternative pathways or the stabilization of proteins that interact with NYD-SP15, thereby enhancing its activity.Similarly, inhibitors of CaMKII, like KN-93, and calmodulin antagonists, such as W-7, might influence the calcium signaling pathways that are crucial for the regulation of numerous cellular processes, including those potentially involving NYD-SP15. The modulation of these pathways can lead to changes in the activity of proteins that, in turn, might enhance the function of NYD-SP15.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Guanosine 5′-triphosphate trisodium salt | 36051-31-7 | sc-215111 sc-215111A | 10 mg 25 mg | $46.00 $71.00 | ||
GTP is essential for signal transduction in the G-protein signaling pathway, where its binding to G-proteins activates them. Active G-proteins can lead to activation of downstream effectors that interact with NYD-SP15, enhancing its activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing levels of cAMP, which in turn activates PKA. PKA can phosphorylate substrates that may interact with NYD-SP15, potentially enhancing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate a wide range of proteins. PKC-mediated phosphorylation of proteins within NYD-SP15’s pathway can enhance the functional activity of NYD-SP15. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent protein kinases that may modulate NYD-SP15’s activity indirectly. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin receptor activation stimulates the PI3K/Akt signaling pathway, which can lead to the activation of downstream proteins that may enhance the activity of NYD-SP15. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3β, which could prevent the inactivation of proteins within Wnt signaling, a pathway that might intersect with NYD-SP15’s function, hence enhancing its activity. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate inhibits protein tyrosine phosphatases, leading to enhanced tyrosine phosphorylation of proteins that could be part of NYD-SP15’s signaling cascade, thus indirectly enhancing its activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that activates PKA, which may phosphorylate proteins within the signaling pathways involving NYD-SP15, leading to increased functional activity. | ||||||
Spermine | 71-44-3 | sc-212953A sc-212953 sc-212953B sc-212953C | 1 g 5 g 25 g 100 g | $61.00 $196.00 $277.00 $901.00 | 1 | |
Spermine can modulate the activity of various ion channels and may influence intracellular signaling pathways that could intersect with the functional activity of NYD-SP15. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
NAD+ is a substrate for sirtuins and PARP, which are involved in deacetylation and ADP-ribosylation of proteins, respectively. These modifications can influence signaling proteins that interact with NYD-SP15, potentially enhancing its activity. | ||||||